Randomized, placebo-controlled trial of Gorei-san enteroclysis in pediatric infectious gastroenteritis
Not Applicable
Recruiting
- Conditions
- Infectious gastroenteritis
- Registration Number
- JPRN-UMIN000017655
- Lead Sponsor
- Division of Pediatrics, Shikoku Central Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with vomiting symptoms associated with other diseases such as congenital disease, urinary tract infection, and acute appendicitis 2) Patients who took Gorei-san 3) Patients who are disqualified by the doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time until liveliness (scored by modified performans status) becomes 0
- Secondary Outcome Measures
Name Time Method Reduction in severity by the Modified Vesikari Score
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Gorei-san's efficacy in pediatric infectious gastroenteritis?
How does Gorei-san enteroclysis compare to standard-of-care treatments for pediatric infectious gastroenteritis?
Are there specific biomarkers that predict response to Gorei-san in pediatric gastroenteritis cases?
What are the potential adverse events associated with Gorei-san enteroclysis in children?
What related compounds or combination therapies are being explored for pediatric infectious gastroenteritis?